logo

For the Inventor, By the Inventor

Pleasanton, CA, United States of America

Keunho Ahn

This inventor holds 5 USPTO granted patents and 4 published patent applications. Top assignee: Slingshot Biosciences, Inc.. Active years: 2024-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Keunho Ahn. Retrieved from https://idiyas.com/inventor/keunho-ahn-iodfc6l2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:

goldMedal5 out of 25 
 
Slingshot Biosciences, Inc.
 patents

Years Active: 2024-2025

Loading Chart...
5 patents (USPTO):Explore Patents
1. 12379387 - Engineered particles as red blood cell mimics and compositions containing same for hematology (2025-08-05),
2. 12332241 - Apoptotic cell mimic (2025-06-17),
3. 12312595 - Hydrogel particles as feeder cells and as synthetic antigen presenting cells (2025-05-27),
4. 12134779 - Hydrogel particles as feeder cells and as synthetic antigen presenting cells (2024-11-05),
5. 12130285 - Apoptotic cell mimic (2024-10-29),

Title: Top Inventor in Pleasanton

Introduction: Yang Tang is a prominent inventor known for his significant contributions to various fields.

Latest Patents: His recent patents include innovative solutions that address contemporary challenges.

Career Highlights: Throughout his career, Yang has achieved numerous accolades and recognition for his work.

Collaborations: He has collaborated with various organizations and institutions to further his research and development efforts.

Conclusion: Yang Tang continues to be a leading figure in innovation, inspiring future generations of inventors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…